About
Small molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (7)
Christopher J
Castle Creek Biosciences
team_member
David Chu
Castle Creek Biosciences
team_member
Matthew CrabtreeVice President
Castle Creek Biosciences
team_member
Matthew Gantz
Castle Creek Biosciences
team_member
Michael Townsley
Castle Creek Biosciences
team_member
Rhea Williams
Castle Creek Biosciences
team_member
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
16
As Collaborator
0
Total Enrollment
1,146
By Phase
PHASE3: 4PHASE1/PHASE2: 2PHASE2: 5PHASE2/PHASE3: 1
By Status
COMPLETED: 7TERMINATED: 6RECRUITING: 1ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
Hover over trial bars to see details
Recent Trials
NCT06892639Lead Sponsor
Evaluation of D-Fi for the Treatment of Wounds Due to DEB
PHASE3Recruiting
32 participants
Started: Mar 27, 2025 · Completed: Feb 28, 2042
NCT04213261Lead Sponsor
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
PHASE3Active, not recruiting
6 participants
Started: Jun 9, 2020 · Completed: Jul 31, 2037
NCT03740724Lead Sponsor
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
PHASE1/PHASE2Terminated
1 participants
Started: Dec 18, 2019 · Completed: Apr 21, 2022
NCT02810951Lead Sponsor
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
PHASE1/PHASE2Terminated
6 participants
Started: Jul 1, 2016 · Completed: Apr 18, 2022
NCT02407561Lead Sponsor
Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays
N/ATerminated
3 participants
Started: Feb 28, 2015 · Completed: Jul 31, 2016
Locations (1)
Headquarters
Exton, PA, United States
Map
Loading map...